Anixa Biosciences (NASDAQ:ANIX – Get Free Report) is expected to be posting its quarterly earnings results before the market ...

Find the latest Anixa Biosciences, Inc. ANIX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lewis (JO:LEWJ) H. Titterton Jr., a director at Anixa Biosciences Inc. (NASDAQ:ANIX), has recently purchased additional shares of the company's common stock. The purchase comes as the stock has ...

Stay updated on market trends for ANIX. EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy FDA Approves Anixa Biosciences' Ovarian ...

S AN JOSE, Calif.— Lewis (JO:LEWJ) H. Titterton Jr., a director at Anixa Biosciences Inc. (NASDAQ:ANIX), has increased his stake in the company with a recent purchase of common stock. According ...

ANIX stock opened at $2.87 on Tuesday. The firm has a market capitalization of $92.41 million, a PE ratio of -7.36 and a beta of 0.93. Anixa Biosciences has a 1-year low of $2.07 and a 1-year high ...